For example, preclinical studies demonstrated an enhanced antitumor activity of granulocyte–macrophage colony-stimulating factor (GM-CSF) or IL-2 producing murine colon tumor cell vaccines [9, 10] and each cytokine have been used as an adjuvant with cancer vaccines [11, 12]. Here, CSF2 is linked to colonic neoplasm.